Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21Uterine Cervical Neoplasms 15Esophageal Neoplasms 3Endometrial Neoplasms 3Breast Neoplasms 3Vaginal Neoplasms 2Rhabdomyosarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Melanoma 2Uveal Melanoma 1Uterine Neoplasms 1Sarcoma 1Retinoblastoma 1Recurrent Head and Neck Carcinoma 1Prostatic Diseases 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Gynecologic Cancer 1Esophageal Squamous Cell Carcinoma 1Endometrial Clear Cell Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Cervical Adenocarcinoma 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

darolutamide 2olaparib 1gedatolisib 1gallium 68 PSMA-11 1Surveys and Questionnaires 1Radiotherapy 1Prostate-Specific Antigen 1Pluvicto 1Nivolumab 1Lutetium-177 1Lutetium 1Cryotherapy 1Brachytherapy 1Androgen Antagonists 1Abiraterone Acetate 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Diseases × Brachytherapy × 1 year × Clear all
NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Active not recruiting
44 enrolled
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡